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Abstract
The progression and variation of pathology during infections can be due to components from both host or pathogen, and/
or the interaction between them. The influence of host genetic variation on disease pathology during infections with
trypanosomes has been well studied in recent years, but the role of parasite genetic variation has not been extensively
studied. We have shown that there is parasite strain-specific variation in the level of splenomegaly and hepatomegaly in
infected mice and used a forward genetic approach to identify the parasite loci that determine this variation. This approach
allowed us to dissect and identify the parasite loci that determine the complex phenotypes induced by infection. Using the
available trypanosome genetic map, a major quantitative trait locus (QTL) was identified on T. brucei chromosome 3
(LOD=7.2) that accounted for approximately two thirds of the variance observed in each of two correlated phenotypes,
splenomegaly and hepatomegaly, in the infected mice (named TbOrg1). In addition, a second locus was identified that
contributed to splenomegaly, hepatomegaly and reticulocytosis (TbOrg2). This is the first use of quantitative trait locus
mapping in a diploid protozoan and shows that there are trypanosome genes that directly contribute to the progression of
pathology during infections and, therefore, that parasite genetic variation can be a critical factor in disease outcome. The
identification of parasite loci is a first step towards identifying the genes that are responsible for these important traits and
shows the power of genetic analysis as a tool for dissecting complex quantitative phenotypic traits.
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Introduction
Forward genetics provides a powerful tool for analysing
phenotypes and identifying genes that are responsible for a
number of important traits. The importance of the linkage
mapping approach is particularly appropriate for the analysis of
phenotypes for which there is no obvious candidate gene, or when
more than one gene is predicted to be involved in a phenotype, so
called complex traits or quantitative trait loci. Such quantitative
traits include disease severity, where there is a range of
pathogenesis phenotypes caused by a particular pathogen.
African trypanosomes cause a disease syndrome of high
morbidity and mortality across large areas of sub-Saharan Africa
in both humans (sleeping sickness) and domesticated animals
(Nagana). The parasites are spread by blood-feeding tsetse fly
vectors (Glossina ssp.), which inject the organisms into the
mammalian host’s bloodstream where they replicate extracellu-
larly resulting in a chronic wasting condition. Two subspecies of
Trypanosoma brucei, T. b. rhodesiense and T. b. gambiense, are able to
infect humans causing a disease that is normally fatal and affects
approximately 70,000 people per year [1] (although this number is
undoubtedly a gross underestimate [2]). In livestock, tens of
millions of animals are affected each year with T. brucei and the
related pathogens T. congolense and T. vivax [3].
In any host-pathogen relationship, variation in disease
outcome can arise from differences between either hosts,
pathogens, or both. In trypanosome biology, variation in
parasite virulence has been well documented but the genetic
basis for this has been largely unexplored. Classically, the two T.
brucei subspecies have been described as causing different
pathology; T. b. rhodesiense causes a short, acute disease, while
that seen with T. b. gambiense is more chronic and less severe [4].
However, the clinical distinctions are unquestionably less clear
than textbooks suggest. Laboratory experiments have demon-
strated differences in pathogenicity during mouse infections with
different strains of T. b. gambiense [5,6], and recently it has been
shown that there is markedly different pathology elicited in
terms of disease severity and progression between T. b. rhodesiense
patients in geographically distinct areas in Uganda and Malawi
[7,8]. In the major cattle pathogens, T. congolense and T. vivax,
variation between isolates in clinical pathology are also well
documented [9,10,11].
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attributed to trypanosome genetic variation has been experimen-
tally demonstrated in mice in several studies using T. brucei and T.
congolense [12,13]. Thus, variation is well known and clinically
important. The genetic basis for this variation however, has not
been investigated. This is in marked contrast to the very
considerable effort that has been directed towards dissecting the
genetic basis behind variation in pathology (‘trypanotolerance’)
attributable to the mammalian host in response to infections with
the major veterinary pathogen, T. congolense in both mice [14,15]
and cattle [16]. These studies have resulted in the identification of
loci in both host systems that contribute to the control of infection.
As all three major African trypanosome species are responsible
for a wide range of virulence phenotypes, understanding the genetic
determinants of this variation is an essential factor to be integrated
into any model of pathogenesis of trypanosomiasis [7,12,17].
Therefore, the contribution of the host to the control of disease and
the parasite to the pathogenesis must both be examined in order to
produce a holistic picture of host-parasite interactions and the
survival of the host. Observed differences in virulence between
trypanosome strains point to a genetic basis for the spectrum of
disease caused in the host and therefore provide a route for
identifying the parasite factors that cause disease in the mammalian
host. The use of a classical genetic linkage mapping approach, in
which the inheritance of phenotypic traits are analysed in progeny
of genetic crosses and examined for co-segregation with genetic
markers, is a valuable route to identifying genes and loci that has
been used for a number traits in pathogenic parasites. This
approach is dependent upon the development of a genetic map for
each species. Recently, genetic maps have been generated for a
numberof haploid parasites, forexample,Plasmodium falciparum[18],
Plasmodium chabaudi [19], Toxoplasma gondii [20], and Eimeria tenella
[21], opening up the possibility of using classical genetic analysis to
identify genes involved in important phenotypes. For example, the
identification of protective antigens that enable survival upon
exposure to the host immune response in Eimeria species [22] and P.
falciparum [23], a gene that influences the ability to invade red blood
cells in P. falciparum [24], and genes that confer resistance to
chloroquineand quinineinP. falciparum [25,26].Thehaploidnature
of these organisms means that the contribution of a single allele to a
phenotype can be measured in isolation without the complication of
an effect of a second allele, allowing for the identification of genes
involved in various phenotypes via a linkage mapping approach
with remarkably few progeny.
Perhaps the most compelling case for the power of genetic
analysis is that of parasite virulence in T. gondii, whereby
Quantitative Trait Loci (QTL) associated with virulence were
identified [20], which directly led to the identification of secreted
kinases as the key genes involved in strain specific pathogenesis of
toxoplasmosis [27,28,29]. Indeed, the relevance of these genes has
been confirmed in T. gondii field strains [30] and these latter studies
elegantly underline the application of the classical genetic
approach to identifying genes of large effect in parasites [31,32].
The development of genetic maps for two sub-species of T. brucei,
T. b. brucei and T. b. gambiense [33,34] provides the potential for
using a classical genetic approach in this organism, although the
diploid nature of this parasite means that only phenotypes that are
heterozygous in the parental strain for which the map was
generated can be mapped using F1 progeny.
Pathology in trypanosome-infected hosts is multi-faceted and we
have chosen to focus on four indices of pathology; anaemia,
reticulocytosis, splenomegaly and hepatomegaly. These traits are
all important in both humans and cattle in infections with all three
species of trypanosome [11,35,36]. Here, we report a genetic
analysis of these inherited host pathology traits and show that two,
splenomegaly and hepatomegaly, resulted in a highly significant
QTL on chromosome 3 of the T. brucei genome.
Methods
Ethics statement
The maintenance and care of experimental animals complied
with the appropriate legislation; the UK Animals (Scientific
Procedures) Act, 1986, and with the national and University of
Glasgow maintenance and care guidelines.
Trypanosomes
A panel of 39 independent F1 T. brucei progeny clones had been
previously generated from a genetic cross between a strain
originally isolated from a tsetse fly (TREU927) and a second
isolated from a hartebeeste (STIB247) [37,38]. Parental and
progeny clones were previously genotyped for 182 microsatellite
markers [33] and thirty one progeny were used in the current
study (Fig. 1). The eight further clones isolated from the
TREU927/STIB247 cross are only available at present as the
insect life cycle stage procyclic forms and are thus not suitable for
in vivo mammalian studies. The two parental lines were each
transmitted through tsetse flies and recloned (using methods
described in [37]) so that their transmission/passage history was
very similar to that of the hybrid progeny. All parasites used
readily infect rodents and passages in our laboratory are kept to a
maximum of six times in mice from tsetse transmission, in order to
maintain tsetse transmissibility and minimise selection by growth
in rodents [39]. Five mini- and microsatellite markers, all on
different chromosomes of T. brucei, were used for routine
genotyping of all infections (Ch1/MS42, Ch2/PLC, Ch3/IJ15/
1, Ch5/JS2 and Ch9/49; for primer sequences and PCR
conditions see [33]).
Animal infections
Parasites were grown from stabilates (cryopreserved in liquid
nitrogen) in a donor ICR mouse (Harlan, UK). Parasites in
Author Summary
Trypanosomes are single-celled organisms that are trans-
mitted between animal hosts by the tsetse fly. These
parasites infect a wide range of mammals and in sub-
Saharan Africa are extensively debilitating to livestock, and
some species are also able to infect humans causing a
disease, sleeping sickness, that is usually fatal unless
treated. Some trypanosome strains cause more severe
disease than others, and studying these differences may
allow the identification of how serious disease is caused.
We approached this problem by looking at how differenc-
es in disease symptoms (enlarged spleen and liver, and
reduced blood cell numbers) that are caused in infections
in mice with two strains of Trypanosoma brucei, TREU927
and STIB247. These disease manifestations are clinically
relevant in human and livestock trypanosome infections.
Examining how the symptoms are inherited in infections
with offspring of a cross between the two strains allowed
the identification of a region of the T. brucei genome that
contains a gene (or several genes) that contributes
significantly towards the enlarged spleen and liver
observed in infected mice. This is a first step towards
identifying the parasite genes that cause disease in the
host (virulence factors), which may provide routes for
developing novel therapies against the disease.
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terminal exsanguination. The trypanosomes were counted in
triplicate in an improved Neubauer haemocytometer, and diluted
in Carter’s Balanced Salt Solution (CBSS) to 1610
4 trypanosomes
per 0.2 ml inoculum. Parasites were then inoculated via the
intraperitoneal route into experimental BALB/c mice (Harlan,
UK). Five mice were infected per strain, and an equivalent
number of uninfected mice were included as controls. Infections
with all of the progeny were completed in nine different batches
and, in each case, infections with both parental strains were used
to ensure consistency of phenotypes across all of the mouse
batches, and to provide a means of minimising batch-to-batch
variation (see below). At day 10 post-infection, mice were
euthanased. Day 10 was chosen as it was the time point at which
the greatest number of pathogenesis phenotypes were significantly
different between the parental strains [Morrison et al., submitted].
Phenotype measurements
We chose to measure two features that can be readily related
to known clinical pathology in multiple host species –
organomegaly and anaemia. At day 10 post-infection, mice
were euthanased and the spleen and liver dissected and weighed.
After weighing, the spleens were snap frozen in liquid nitrogen,
and stored at 280uC. A FACs based assay was developed to
measure anaemia in the mouse model [Morrison et al.,
submitted]. Briefly, parameters for FACs analysis were deter-
mined for each cell population (trypanosomes, red blood cells,
reticulocyctes and white blood cells), by assaying each population
in isolation with a known number of fluorescent beads, allowing
the gating and calculation of cell populations from whole
infected blood. For each strain 5 ml blood was collected and
added to 2 ml of in CBSS containing 100 U/ml heparin,
followed by the addition of 198 ml 1% paraformaldehyde in
PBS pH 7.4, mixed thoroughly to ensure no aggregates formed
and fixed for 30 minutes at room temperature. To stain
reticulocytes, 745 ml thiazole orange (100 ng/ml in PBS
pH 7.4) was added to the blood/fixative mixture and allowed
to stain for 1 hour in the dark at room temperature [40].
Fluorescent beads (Countbright
TM absolute counting beads for
flow cytometry, Invitrogen, UK) were prepared by diluting to
1000 beads/ml and ensuring even mixing by sonication. Fifty ml
of the bead mixture was then added to the blood/thiazole orange
preparation (total volume 1 ml; 50,000 beads/ml). FACS was
carried out using a Becton Dickinson FACSCalibur, using
detector FL1-H for thiazole orange. Data were analyzed using
CellQuest version 3.3. For each sample 10,000 events were
Figure 1. Average phenotype values for infections with STIB247 (grey bar) and TREU927 (black bar) in comparison with uninfected
controls (clear bar), for spleen weight, liver weight, red blood cell numbers and percentage reticulocytes. Values are mean695%
confidence interval (n=5).
doi:10.1371/journal.pntd.0000557.g001
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described by Antoine-Moussiaux et al [41] and is described in
full in Morrison et al (submitted).
Data and QTL analysis
The data for all four phenotypes were normally distributed
(D’Agostino-Pearson normality test, p.0.05 in all cases), and this
allowed calculation of Pairwise correlations of phenotype data
using Pearson correlation coefficient and a two-tailed P-value, and
from this a value of r
2 was generated. For QTL analysis, the mean
phenotype value for each progeny clone was calculated as a
percentage of the phenotype for the TREU927 parental strain in
that particular batch to take batch-to-batch variation into account.
QTL analysis was performed using MapManager QTX software
[42] for the T. brucei genetic map [33]. The variance was
calculated from the five biological replicates of each phenotype for
each progeny. The Likelihood Ratio Statistic (LRS) significance
values were calculated by 1000 random permutations of the
phenotypes relative to the genotypes that were intrinsic to the
experimental data set (to obtain the equivalent LOD score, the
LRS is divided by approximately 4.6). Thresholds of statistical
significance (x
2 statistic) were calculated from each permutation
test for each phenotype. The calculated threshold values were in
line with those suggested for genome-wide scan studies [43]. For a
simplified explanation of the inheritance model and relevant
features of the TREU927 6STIB247 cross see Fig S1.
Marker generation and update of the genetic map
An additional genetic marker, (TB3/19), was developed for T.
brucei chromosome 3 based on the allele specific amplification of a
1 kb fragment of DNA of the TREU927 parental strain and the
failure to amplify the other TREU927 allele or STIB247 parental
alleles, due to a single nucleotide polymorphism in the primer
site(s). As a positive control for DNA integrity, primers directed
against a second non-polymorphic 1 kb fragment were used (TB3/
20), which amplified both TREU927 alleles. This allele-specific
PCR (TB3/19) segregated in the progeny and was incorporated
into the genetic map. Primer sequences were Ch3/19A TGA-
GTTCCTCTTGCACTCCC, Ch3/19B TCTTTACGTGT-
GCGCGCTAGG, Ch3/20A GATGTAATGTCCCTTCGGA-
TTGCG and Ch3/20B GTGTCTTGTAGTTTATGACGGC;
PCR conditions were described previously [33]; Genotyping gaps
in the original map were also filled (for version 2 of the genetic
map, see http://tinyurl.com/trypmap).
Results
Phenotype measurements
The trypanosomes strains TREU927 and STIB247 consistently
differ in the pathogenesis they induce, including the degree to
which they cause anaemia, reticulocytosis, splenomegaly and
hepatomegaly (Fig 1). We measured these parameters in nine
batches of mice and consistently observed the same pattern with
greater splenomegaly and reticulocytosis in 247-infected mice and
marked anaemia in 927-infected mice (Fig 1 and Fig S2). Whilst
the patterns were consistent, the absolute values showed some
batch-to-batch variation and to account for this, subsequent data
are presented as percentages of the 927 parental levels. A detailed
analysis of hepatomegaly development over multiple time points
permitted robust statistical analysis by 2-way ANOVA and showed
hepatomegaly to be greater in STIB247-infected mice [Morrison
et al, submitted], although the data for day 10 show a smaller
difference than was observed for the other three phenotypes (Fig
S2).
In order to investigate if there is a genetic basis for this variation
in these phenotypes, experimental mouse infections were carried
out with 31 independent F1 progeny from a genetic cross between
TREU927 and STIB247. The mean data for each phenotype for
each progeny clone are illustrated in Figure 2, revealing a
continuous distribution for each phenotype. All four phenotypes
show marked transgressive segregation with between 10 and 20
hybrids displaying average values outside the parental range.
Interestingly, few values fall below that observed for TREU927
and a large number of the progeny display values far greater than
either parent. This heterosis was particularly marked for
splenomegaly, hepatomegaly and reticulocytosis but less so for
red cell numbers. All four phenotypes show classical quantitative
inheritance with no clear segregation into different classes in the
progeny, but the progeny clones at the top and bottom ends of
each distribution show clear and reproducible differences,
suggesting that parasite derived genetic determinants contribute
to each phenotype.
Pairwise correlations were calculated for all phenotypes,
revealing three combinations that show significant correlation
(Fig 3). The most significant correlation was between red blood cell
numbers and percentage reticulocytes, which suggested that 57%
of the variance is shared between the two phenotypes. There were
also significant correlations between liver and spleen weights (44%
of shared variance) and reticulocyte percentage and liver weight
(21%).
Linkage analysis
The relatively continuous distribution of phenotypic data from
the F1 progeny in all cases suggests that multiple loci are involved
in determining the phenotype. In order to investigate the genetic
basis determining these traits a quantitative linkage mapping
approach was therefore applied to the data using the available
genetic map. The T. brucei genetic map created from a TREU927
6STIB247 cross [33] comprising 196 markers spread across the
11 megabase chromosomes (but not covering subtelomeric
regions, or mini – and intermediate chromosomes), was used to
analyse whether the phenotypes (spleen weight, liver weight,
reticulocyte percentage and red blood cell numbers) co-segregated
with genetic markers, using QTL analysis.
Splenomegaly and hepatomegaly. Two phenotypes,
splenomegaly and hepatomegaly, showed evidence for highly
significant QTLs, mapping to the same region on chromosome 3
with equivalent LOD scores of 7.2 and 7.5, respectively (Fig 4;
Table 1). The hepatomegaly QTL had a significance level of
p#0.001 for a genome-wide analysis, and was estimated to
account for approximately 64% of the phenotype variance. The
splenomegaly QTL was also highly significant (p#0.001), and
contributed a similar amount (66%) to the phenotype variance.
Interval mapping confirmed in both cases that the QTL lies
between markers TB3/3 and TB3/10, a region that covers
56.3 cM (physical region between 462529 bp and 1460975 bp, a
physical distance of 998446 bp) and which contains 383 genes
(Fig 5). For hepatomegaly there is no suggestion of more than one
locus involved within the interval of the QTL. However, for
splenomegaly although the QTL remains significant between
TB3/3 and TB3/10, there are two distinct regions within the
QTL showing highly significant linkage (between TB3/3 and
TB3/5, and TB3/6 and TB3/10, respectively, Fig 5). This may
indicate that there is more than one locus involved in
splenomegaly within the context of the QTL (and indeed this
could also be the case for hepatomegaly), but this will require
further work to fully elucidate. As well as the linkage described
above, the hepatomegaly phenotype also shows significant
A Trypanosome QTL for Pathology in the Host
www.plosntds.org 4 December 2009 | Volume 3 | Issue 12 | e557Figure 2. Average phenotype values for infections with the 31 F1 progeny. Measurements taken were A) spleen weight, B) liver weight, C)
red blood cell numbers, D) reticulocyte percentage (error bars are 95% confidence interval). Phenotypes are expressed as percentage of the value of
the mice infected with TREU927 in the respective batch of infections, and are arranged in ascending order. The mean value for the STIB247 infections
is shown (grey bar) and the TREU927 value (100%) is indicated by a solid line. Progeny names are as in the TREU9276STIB247 genetic map (see [38]).
doi:10.1371/journal.pntd.0000557.g002
A Trypanosome QTL for Pathology in the Host
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7, and 11 and splenomegaly to QTLs on chromosomes 1, 2 and 10
(Fig 3; Table 1).
Anaemia (red blood cells and reticulocytosis). Linkage
analysis of percentage reticulocytes revealed significant linkage to
three loci on chromosomes 2, 8 and 11, but linkage hinged upon a
Figure 3. Pairwise correlations between phenotypic data for infections with parents and progeny (significance p,0.05; Pearson
correlation coefficient). The p-value and r
2 value are indicated in each graph, and the line of best fit is also shown (dotted lines indicate the 95%
confidence interval). Parental values are shown in each case, with the TREU927 value represented by the red triangle, and the STIB247 value by the
inverted blue triangle.
doi:10.1371/journal.pntd.0000557.g003
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false positive linkage is a possibility. However there are five
markers displaying linkage to the same region on chromosome 2,
indicative of a genuine QTL (Fig 4; Table 1). Interestingly these
overlapping minor QTLs on chromosome 2 appear to be
significantly linked to three of the four phenotypes measured in
this study: hepatomegaly, splenomegaly and reticulocytosis (Fig 4;
Table 1).
For the red blood cell phenotype, two loci were identified as
being significantly linked on chromosomes 10 and 11. However,
Figure 4. Genome-wide linkage scans for splenomegaly, hepatomegaly, red blood cell numbers and reticulocyte percentage. The
graphs show a genome scan of interval mapping for each phenotype from chromosome 1 to 11 of Trypanosoma brucei, with the Likelihood Ratio
Statistic (probability of linkage of phenotype to genotype; black line) measured in a stepwise manner at 1 cM intervals across the length of the
genome; chromosome numbers are shown on the x-axis (the scale on x-axis is in cM). The dashed and dotted lines represent the thresholds of
significance (p,0.05) and high significance (P,0.001), respectively, for a genome-wide analysis. For reference, the p,0.05 threshold is approximately
equivalent to a LOD score of 3.
doi:10.1371/journal.pntd.0000557.g004
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as either minor loci or a result of a false positive linkage (Fig 4;
Table 1).
In summary, we have identified one highly significant locus on
T. brucei chromosome 3 that accounts for approximately two thirds
of the variance observed in splenomegaly and hepatomegaly,
which we name TbOrg1 (for T. brucei organomegaly QTL 1). The
significance of the QTL on chromosome 3 is reinforced by the fact
that both phenotypes show a strong correlation with each other
(Fig 3) and link to this region. There is also a smaller, but still
significant, locus on chromosome 2 that contributes to strain-
specific splenomegaly, hepatomegaly and reticulocytosis, named
TbOrg2. The importance of TbOrg2 is enhanced by the fact that
three phenotypes are all significantly linked to the locus (Fig 4),
contributing approximately 30–35% to each of the phenotypes,
and this therefore represents a parasite locus that has a minor but
multifactorial effect on pathogenesis in the mouse host. We
conducted a secondary screen after fixing TbOrg1 on chromosome
3, for both splenomegaly and hepatomegaly, but this did not reveal
any further significant loci (data not shown).
Discussion
We have used genetic linkage analysis to investigate a variety of
pathogenesis phenotypes in infections with T. brucei. Our
approach, using genetically distinct parasite strains in one inbred
host background effectively means that observed differences in
infection profile must originate from parasite genotype differences.
Differences caused by host factors also exist, but have been
minimised by the use of inbred mice and controlling for any batch-
to-batch variation. Our results clearly show that variation in
pathology has a parasite determined genetic basis and that using a
linkage mapping approach it was possible to identify a region of
the genome on chromosome 3 that has a major effect on the gross
pathology in mice. This study is an important step, therefore,
towards identifying the parasite virulence factors that underlie
differential pathogenesis.
The phenotype data in this study do not segregate in a manner
that would indicate they are determined by a single gene, unlike
that of previous studies in haploid parasites, where traits in
progeny could definitively be scored as (for example) virulent,
intermediate or non-virulent [20], or drug resistant or sensitive
[25]. The phenotypes we have examined are, or undoubtedly can
be, the end product of multiple processes, and therefore will have
multiple genes contributing to the variance. They are therefore
true ‘quantitative traits’, and for this reason QTL analysis was the
most appropriate tool to search for linkage between trypanosome
genotype and host infection phenotype. The identification of a
highly significant QTL, despite the complex nature of the
phenotypes, suggests that we have identified a parasite locus that
determines a process responsible for a large proportion of the
variance observed.
The correlation of liver and spleen weights, and linkage of each
to the same region of chromosome 3, means that it is reasonable to
assume that the same locus is responsible for the differential
pathogenesis in both phenotypes. Whether this is due to a parasite
gene product directly influencing both processes individually, or
whether the gene product defines the polarisation or sequence in
which multiple downstream host and parasite pathways proceed, is
one of the questions that remain to be answered. Certainly the
spleen and liver are significant organs with respect to the response
to infection, and splenomegaly is one of the classical clinical signs
observed in experimental cases of animal trypanosomiasis and also
in natural cases of animal and human disease [35,44,45]. The
spleen and liver obviously both have roles with respect to the
innate immune response [46] and, with respect to trypanosome
Table 1. Quantitative Trait Loci for splenomegaly, hepatomegaly, red blood cell numbers and reticulocyte percentage, that are
significant (p,0.05) and highly significant (p#0.001) in a genome-wide screen.
Phenotype Chromosome Number of marker(s)* Marker above significance threshold Significance
Spleen 1 1 TB1/1 p,0.05
2 5 TB2/16-TB2/20 p,0.05
3 9 TB3/3-TB3/10 p#0.001
10 1 TB10/6 p,0.05
Liver 2 4 TB2/22-TB2/6 p,0.05
2 4 TB2/13-TB2/16 p,0.05
3 9 TB3/3-TB3/10 p#0.001
4 3 TB4/16-TB4/11 p,0.05
5 2 TB5/2-TB5/1 p,0.05
6 5 TB6/2-TB6/6 p,0.05
7 2 TB7/1-Tb7/2 p,0.05
11 2 TB11/3-TB11/4 p,0.05
11 2 TB11/19-Tb11/20 p,0.05
Red blood cells 10 1 TB10/2 p,0.05
11 1 TB11/5 p,0.05
Reticulocytes 2 5 TB2/6-TB2/12 p,0.05
8 1 TB8/5 p,0.05
11 1 TB11/5 p,0.05
*Number of markers that are significant or highly significant (range of markers is indicated in brackets – for details see http://tinyurl.com/trypmap). Highly significant
QTLs are shown in bold.
doi:10.1371/journal.pntd.0000557.t001
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response proceeds seems to determine the progression of disease
[47,48,49,50]. We have previously shown that in infections with
the two parental strains, pathways of the innate immune response,
macrophage polarisation (IL10, RXR/LXR pathways), and
alternative macrophage activation are the most significantly
differentially regulated [Morrison et al., submitted]. The strain
specific pathogenesis is therefore not only due to a difference in
magnitude of the same pathways, but distinct pathways. It seems
reasonable, therefore, to postulate that there is a parasite gene
product that determines this polarisation, and the gene is located
within the locus on chromosome 3.
The confidence interval of the major chromosome 3 QTL for
splenomegaly and hepatomegaly (TbOrg1) includes 383 genes. Of
the genes within the QTL, 206 are conserved hypothetical
proteins, 109 have function assigned by sequence homology, 62
have a predicted signal peptide, 10 are sequence orphans, 3 are
pseudogenes and only 16 have been experimentally characterised
(Table S1). Given the number of candidate genes, a fine-mapping
approach is required to narrow down the region of linkage and
reduce the number of genes to a level where candidates can be
experimentally examined. There is scope for this approach, as the
QTL interval for both phenotypes contains 12 crossovers in the 31
progeny, and therefore informative markers will further define the
linkage boundaries. Fine mapping, in which more informative
genetic markers within the QTL region are identified, can be
undertaken in a number of ways, the most definitive of which will
be to sequence the genomes of the parental strains to identify all
single nucleotide polymorphisms within the locus, which can then
be used to define the crossover boundaries in the progeny more
precisely. There are additional and complementary techniques
that will also aid in defining candidate genes, for example; the
generation of further progeny in order to incorporate a greater
number of informative crossovers in the genetic map and the
identification of genes that are heterozygous for 927 (by identifying
heterozygous single nucleotide polymorphisms (SNPs) in the
relevant chromosome sequence) within the QTL (given the
necessity for the gene to be heterozygous to obtain segregation
in this cross). Additionally, gene expression data could be used to
rule out, for example, those genes only expressed in the procyclic
life cycle stage, and inferences of gene function could also be made
from the genome sequence data. Similar post-genomic approaches
were used successfully to identify T. gondii virulence factors, when
starting from QTLs spanning regions of a similar magnitude [27].
Additionally, while the approach using F1 progeny clearly allows
the identification of dominant heterozygous loci (Fig S1), a
limitation is that it will not detect co-dominant or recessive loci.
Therefore, using the same approach, but with an F2 cross, would
allow the dissection of further loci that are not detectable with the
current approach, and provide a more comprehensive picture of
the parasite genes contributing to pathogenesis. However, no
successful F2 cross has been reported in trypanosomes thus far.
The QTLs identified on chromosome 2 for splenomegaly,
hepatomegaly and reticulocytosis (TbOrg2) are potentially interest-
ing. In all three cases there are multiple markers linked and the
loci of the three phenotypes partially overlap, suggesting that the
correlations between the traits (two of which are highly significant
and the third approaches significance) may have some causal basis
worthy of further investigation. In contrast, there are no QTLs in
common for red blood cell numbers and reticulocytosis despite the
very strong correlation between these two traits. One explanation
for this is that the spleen, and to a lesser extent the liver, are
haematopoietic organs, and therefore linked to reticulocyte
production. In contrast, the change in red blood cell numbers
will largely be a function of the erythrophagocytosis that occurs in
early infection [36]. The implication is that, whilst the traits may
be linked mechanistically, the parasite determinants that drive
organomegaly/reticulocytosis and red blood cell numbers may be
different.
In summary, we have demonstrated for the first time that
forward genetics provides a powerful tool to map genes in the
trypanosome genome that are responsible for causing complex
phenotypes in the mouse host. We have defined two loci, one a
major locus on Chromosome 3 (TbOrg1) that contributes to a
significant amount of the variance observed in splenomegaly and
hepatomagaly during mouse infections with T. brucei, and a second
QTL on Chromosome 2 that contributes to splenomegaly,
hepatomegaly and reticulocytosis in these infections (TbOrg2).
Identification of the trypanosome genes that mediate the
differential pathogenesis will provide a fundamental insight into
the mechanisms by which the parasite causes disease in the
mammalian host, and these findings may provide potential for
Figure 5. Significant QTLs for splenomegaly and hepatomegaly
on chromosome 3 of Trypanosoma brucei. The graphs show a
chromosome scan of interval mapping for each phenotype, with the
Likelihood Ratio Statistic (probability of linkage of phenotype to
genotype; black line) measured in a stepwise manner at 1 cM intervals
across the length of chromosome 3; chromosome 3 markers are shown
on the x-axis (the scale on x-axis is in cM). The dashed and dotted lines
represent the thresholds of significance (p,0.05) and high significance
(P,0.001), respectively, for a genome-wide analysis.
doi:10.1371/journal.pntd.0000557.g005
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associated with this pathogen.
Supporting Information
Figure S1 Inheritance model for TREU927 6 STIB247 F1
cross. In this simplified model the phenotype is treated as a binary
trait determined by a single gene. (Spleen +++=significantly
enlarged spleen, spleen +=slightly enlarged spleen; A=dominant
TREU927 allele, a=recessive TREU927 allele, x=STIB247
allele). The cross will allow the detection of traits encoded by a
dominant heterozygous allele in TREU927. The genome of
STIB247 is predominantly homozygous, with 94% of markers
shown to be homozygous [33]. Therefore, the map is constructed
based on segregation of alleles in the F1 progeny for loci
heterozygous in the TREU 927 parent only. In order to detect
co-dominant or recessive alleles, it will be necessary to generate a
panel of F2 progeny. For segregation data see http://tinyurl.com/
trypmap.
Found at: doi:10.1371/journal.pntd.0000557.s001 (0.15 MB TIF)
Figure S2 Phenotype values for mice infected with 927 and 247,
and uninfected mice for the nine batches of mice; A=splenomeg-
aly, B=hepatomegaly, C=red blood cell counts and D=per-
centage reticulocytes. In each batch (1–9), clear bar indicates
uninfected mice, black bar indicates 927-infected mice and the
grey bar indicates 247-infected mice. Values are mean 695% CI
(n=5).
Found at: doi:10.1371/journal.pntd.0000557.s002 (0.66 MB TIF)
Table S1 Gene ID, location and annotation for the 383 genes
within the QTLs for splenomegaly and hepatomegaly.
Found at: doi:10.1371/journal.pntd.0000557.s003 (0.41 MB
DOC)
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